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Mitochondrial dysfunction is a primary event in renal cell ox-
alate toxicity.
Background. In cultured renal epithelial cells, exposure to ox-
alate, a constituent of many kidney stones, elicits a cascade of
responses that often leads to cell death. Oxalate toxicity is me-
diated via generation of reactive oxygen species (ROS) in a pro-
cess that depends at least in part upon lipid signaling molecules
that are generated through membrane events that culminate in
phospholipase A2 (PLA2) activation. The present studies asked
whether mitochondria, a major site of ROS production, were
targets of oxalate toxicity, and if so, whether mitochondrial re-
sponses to oxalate were mediated by PLA2 activation.
Methods. Effects of oxalate and various lipids on mitochon-
drial membrane potential (m) were measured in Madin-
Darby canine kidney (MDCK) cell monolayers using 5,5′,6,6′-
tetrachloro 1,1′,3,3′-tetraethylbenzimidazolylcarbocyanine io-
dide (JC-1), a m-sensitive dye. Other studies assayed cas-
pases, serine proteases activated during apoptosis, in response
to oxalate or lipid signaling molecules. Additional studies asked
whether oxalate or lipids produced by PLA2 activation pro-
moted ROS formation in isolated renal mitochondria.
Results. Oxalate exposure decreased MDCK cell m
within 30 minutes, a response attenuated by arachidonyl triflu-
oromethyl ketone (AACOCF3), an inhibitor of cytosolic PLA2
(cPLA2). Exposure to arachidonic acid or to lysophosphatidyl-
choline (lyso-PC), lipid products of PLA2 activation, or to
ceramide, another lipid signal generated in MDCK cells follow-
ing oxalate exposure, also depolarized MDCK cell m and
increased the number of caspase-positive cells. Isolated renal
mitochondria responded to oxalate, arachidonic acid, lyso-PC,
and ceramide by increasing their accumulation of ROS, lipid
peroxides, and oxidized thiol proteins.
Conclusion. These studies suggest that lipid signaling
molecules released after oxalate-induced PLA2 activation trig-
ger marked, rapid changes in mitochondrial function that may
mediate toxicity in renal epithelial cells.
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Exposure to oxalate, a major component of kidney
stones, elicits a cascade of responses in renal epithe-
lial cells that often leads to cell injury or death [1–12].
Some of these responses are triggered by the activation
of one or more lipid signaling pathways. In particular,
oxalate exposure activates phospholipase A2 (PLA2), an
enzyme that hydrolyzes the acyl group from the sn-2 posi-
tion of phospholipids to generate free fatty acids, includ-
ing arachidonic acid and lysophospholipids, which act as
intracellular signaling molecules [13]. Oxalate exposure
also increases renal cell formation of ceramide [10, 14],
another lipid that serves multiple intracellular signaling
functions [15]. Pretreatment with inhibitors of cytosolic
PLA2 (cPLA2) attenuates the deleterious effects of ox-
alate on renal cell viability [13], impedes many of the
effects of oxalate on immediate early gene expression
[16] and blocks the oxalate-induced increases in ceramide
production [14], suggesting that one or more of the lipid
signals generated in response to PLA2 activation directly
or indirectly mediates oxalate actions.
Numerous studies have suggested that oxalate toxic-
ity is accompanied by the generation of reactive oxygen
species (ROS) in renal epithelial cell cultures [3, 4, 6,
17–19]. Oxalate exposure also imposes an oxidant stress
on renal cells by stimulating the accumulation of lipid
peroxides [5] while decreasing the availability of other
cellular antioxidants, such as reduced glutathione [17].
ROS are produced as a byproduct of electron transport in
mitochondria [20]. Normally, intracellular and intramito-
chondrial antioxidants prevent cellular damage produced
by endogenous ROS, although conditions that increase
ROS generation or diminish antioxidant availability can
yield a net increase in intracellular ROS. Recent evi-
dence suggests that mitochondria are a significant source
of the ROS that are produced in renal cells following
exposure to oxalate or to calcium oxalate monohydrate
(COM) crystals [17]. Thus, mitochondria may be key me-
diators in oxalate-induced cell death, although mecha-
nisms by which oxalate exposure increases mitochondrial
ROS production have not yet been resolved.
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The present studies posed several questions about the
relationship between oxalate exposure and mitochon-
drial function in cultured renal epithelial cells. Because
perturbations in mitochondrial function, in particular, a
loss of mitochondrial membrane potential (m), are
a common occurrence in cell death [21–23], these stud-
ies asked whether exposure to oxalate would trigger a
decrease in m in cultured renal epithelial cells. More-
over, since many of the cytotoxic effects of oxalate on re-
nal epithelial cells appear to be mediated by PLA2 and its
effector lipid signaling molecules [13, 14, 16], the present
studies also tested whether the oxalate-induced changes
in m could be mimicked by lipid signaling molecules
or attenuated by inhibition of PLA2. Additional studies
sought to determine whether oxalate or the lipid signals
produced in response to oxalate exposure could activate
caspases, serine proteases that are often activated dur-
ing apoptosis [24, 25]. Finally, these studies examined
whether oxalate per se, or the lipid signaling molecules
known to be activated in response to oxalate exposure,
could elicit direct effects on renal mitochondrial produc-
tion of ROS, lipid peroxides, and reduced thiol proteins.
METHODS
Chemicals and reagents
Dulbecco’s modified Eagle medium (DMEM) and an-
tibiotics (penicillin/streptomycin) were purchased from
Gibco-BRL (Grand Island, NY, USA). Fetal bovine
serum (FBS), arachidonic acid, and carbonyl cyanide
q-trifluoromethoxyphenylhydrazone (FCCP) were
purchased from Sigma Chemical Co. (St. Louis, MO,
USA). Lysophosphatidylcholine (lyso-PC) (1-palmitoyl-
2-hydroxy-sn-glycero-3-phosphocholine) was procured
from Avanti Polar Lipids (Birmingham, AL, USA).
Arachidonyl trifluoromethyl ketone (AACOCF3) was
purchased from Biomol Research Laboratories (Ply-
mouth Meeting, PA, USA). JC-1 (5,5′,6,6′-tetrachloro-
1,1′,3,3′-tetraethylbenzimidazolylcarbocyanine iodide)
was purchased from Molecular Probes (Eugene, OR,
USA). All other chemicals were of the highest grade
available.
Cell culture
The Madin-Darby canine kidney (MDCK) distal renal
tubular cell line was obtained from the American Type
Culture Collection (ATCC, Manassas, VA, USA); cells
were used between passages 53 and 90. Cells were plated
on 100 mm dishes and grown in DMEM supplemented
with 10% FBS, 100 U/mL penicillin, 100 lg/mL strepto-
mycin and 4.5 g/L D-glucose. Cultures were maintained in
a humidified atmosphere of 95% air and 5% CO2 at 37◦C.
For experiments designed to estimate m, MDCK cells
were grown to confluence on rectangular glass cover-
slips (1 × 2.5 cm). For studies assessing caspase activ-
ity, MDCK cells were grown to confluence on 8-chamber
Lab-TeK@ glass slides (Nalge Nunc International Corp.,
Naperville, IL, USA). For determinations of arachidonic
acid release, cells were grown to ∼80% confluence in 12-
well culture plates.
∆Ψm
Changes in m were estimated in intact MDCK cells
using JC-1, a m-sensitive fluorescent dye [26]. JC-1 is
a positively charged molecule that partitions into mito-
chondria, which, under normal circumstances, have a high
m potential. Mitochondrial accumulation of high dye
concentrations leads to aggregation of the JC-1 molecules
and a shift in spectral emission from green (534 nm) to
red (596 nm). If mitochondria become depolarized, JC-1
redistributes to the cytosol at lower concentration, losing
the red fluorescence characteristic of the dye aggregates.
Calculating changes in the ratio of fluorescence emission
at red (596 nm) and green (534 nm) wavelengths provides
a qualitative estimate of changes in m [27, 28].
MDCK cells were grown to near-confluence on cover-
slips, washed twice in phosphate-buffered saline (PBS),
then incubated for 15 minutes at 37◦C with 5 lg/mL
of JC-1 in a modified Krebs-Ringer Hepes (KRH)
buffer containing 115 mmol/L NaCl, 5 mmol/L KCl, 1
mmol/L KH2PO4, 2 mmol/L CaCl2, 1.2 mmol/L MgCl2,
25 mmol/L Hepes, pH 7.4, and 0.2% bovine serum albu-
min (BSA). After dye loading, coverslips were washed
with KRH buffer, placed in a cuvette containing 2.5 mL
KRH, and transferred to a spectrofluorimeter (Spex Flu-
orolog) (Spex Industries, Inc, Edison, NJ, USA). JC-1
fluorescence was assessed at three different times in each
experiment. At time zero, a baseline emission spectrum
was measured over the range of 510 to 625 nm using an ex-
citation wavelength of 488 nm. MDCK cells were then ex-
posed to various stimuli and the emission spectra assessed
again at 30 minutes. Finally, cells were then exposed for 5
minutes to 5 lmol/L FCCP (a mitochondrial uncoupling
agent) to estimate maximal disruption of m, and the
JC-1 emission spectrum was recorded for a final time.
For each experiment and each time point, the ratio of
JC-1 fluorescence intensity at 596 nm and at 534 nm was
calculated from the emission spectrum and the 596 nm/
534 nm ratio used as a qualitative estimate of m. Data
are expressed as the treatment-induced change in 596 nm/
534 nm fluorescence ratio relative to the initial (control)
596 nm/534 nm ratio. Since this initial ratio varied widely
between experiments (ranging from 0.51 to 10.68 with an
average of 2.65 ± 0.33; N = 55), the ability of FCCP to
dissipate the m, and hence to reduce this ratio, pro-
vided an important control for cell viability on each ex-
perimental coverslip, particularly in experiments in which
the prevention of an oxalate-induced decrease in m
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by PLA2 inhibition was being explored. In most exper-
iments, FCCP treatment reduced the JC-1 fluorescence
ratio to about 40% of its initial value (to an average of
1.10 ± 0.13; range 0.31 to 2.99); MDCK coverslips in
which FCCP produced only modest changes in the JC-
1 ratio (i.e., a decrease of <20% of the starting ratio)
were presumed to be not viable and were discarded.
Experimental design
To assess effects of oxalate on m, JC-1-loaded
MDCK cells were exposed for 30 minutes to 0.5 mmol/L
total sodium oxalate [which yields free oxalate concen-
trations of 175 lmol/L, and produces relative super-
saturation levels (RSS) for calcium oxalate of 12.5, as
estimated by the EQUIL program [29]]. Although this
oxalate concentration is somewhat higher than that es-
timated in collecting duct fluid (100 to 300 lmol/L), it
is within the range that would likely be observed after
consuming an oxalate-rich meal or in patients with hy-
peroxaluria [30].
To determine if lipid signaling molecules that are
known to be increased by oxalate exposure [13, 14,
16] would also influence m, coverslips of JC-1–
loaded MDCK cells were exposed to arachidonic acid
(50 lmol/L), lyso-PC (25 lmol/L), or C2-ceramide
(20 lmol/L) for 30 minutes. Although the intracellular
concentrations of these lipids following oxalate exposure
have not yet been determined in cultured renal cells,
the lipid concentrations selected for the present stud-
ies have been shown previously to reproduce several
oxalate-induced changes in renal cell viability and gene
expression [13, 14, 16].
To determine if oxalate-induced changes in m could
be attenuated by inhibition of PLA2 activity, MDCK cells
were preincubated for 15 minutes in the absence or pres-
ence of 10 lmol/L AACOCF3, a selective inhibitor of
cPLA2, shown previously to inhibit many of oxalate ac-
tions in MDCK cells [13, 14, 16]. MDCK cells then were
loaded with JC-1 for 15 minutes, and subsequently ex-
posed to 0.5 mmol/L sodium oxalate for 30 minutes as
described above.
Measurement of arachidonic acid release
To confirm the efficacy of the cPLA2 inhibitor AA-
COCF3, MDCK cells were grown to subconfluence in
12-well plates, preincubated for 12 to 18 hours with
0.2 Ci/mL [3H]-arachidonic acid in serum-free DMEM,
and washed to remove unincorporated label. Cells were
pretreated for 10 minutes with DMEM alone or with
10 lmol/L AACOCF3, then exposed to 1 mmol/L sodium
oxalate for 60 minutes; [3H]-arachidonic acid release was
measured as described previously [13].
Caspase activation
Activation of caspases in intact MDCK cells was as-
sessed using the CaspaTagTM fluorescein caspase activity
kit (Intergen Company, Purchase, NY, USA). This as-
say uses a carboxyfluorescein derivative of benzyloxy-
carbonyl valyl alanyl aspartic acid fluoromethyl ketone
(zVAD-FMK) to detect active caspases (caspases 1, 2, 3,
6, 8, 9, 10, and Pan) in living cells. MDCK cells were grown
to confluence in 8-chamber glass slides, then treated for 1
hour at 37◦C with 0.5 mmol/L sodium oxalate, 50 lmol/L
arachidonic acid, 20 lmol/L C2-ceramide, or 25 lmol/L
lyso-PC. As a positive control, some cells were treated
with 0.2 lmol/L antimycin A, a mitochondrial electron
transport inhibitor that collapses m, generates ROS
and activates caspases in many cells including cultured
renal epithelial cells [31]. Control and treated cells were
stained using the CaspaTagTM kit according to the man-
ufacturer’s instructions. After washing, the monolayers
were examined using a digital imaging fluorescent micro-
scope (Attofluor RatioVision) (Atto Instrument Co.,
Rockville, MD, USA) monitoring excitation at 488 nm
and emission at ≥520 nm). Caspase-positive cells were
quantitated by counting the number of fluorescent cells
in 15 randomly selected 20× microscopic fields.
Studies on isolated rat kidney mitochondria
To determine whether exposure to oxalate or to lipid
signaling molecules could directly influence mitochon-
drial oxidant status, several experiments were performed
on isolated renal mitochondria. Kidneys from 200g male
Wistar rats were excised, the cortex dissected and ho-
mogenized in an ice-cold buffer containing 0.25 mol/L
sucrose, 10 mmmol/L Tris-HCl, pH 7.4, 1 mmol/L egtazic
acid (EGTA), and 0.5% BSA. Crude mitochondrial frac-
tions were obtained by differential centrifugation [32].
Pellets containing mitochondria were washed twice, and
then resuspended in the same buffer without ethylene-
diaminetetraacetic acid (EDTA). Protein content of the
mitochondrial suspension was determined [33] and ad-
justed to a final concentration of 25 to 50 mg/mL.
ROS production
ROS production in isolated mitochondria was mea-
sured using 2′,7′-dichloro-dihydrofluorescein-diacetate
(DCF-DA), a nonfluorescent dye cleaved to a fluorescent
byproduct (DCF) by reactive oxygen molecules, partic-
ularly hydrogen peroxide [34]. Studies were performed
using a protocol described previously by Cocco et al [35]
with some modifications. Isolated mitochondria (0.5 mg
mitochondrial protein) were suspended in 3 mL of PBS
containing 20 mmol/L sucrose and 2 lmol/L DCF-DA or
in a KRH buffer containing 115 mmol/L NaCl, 5 mmol/L
KCl, 1 mmol/L KH2PO4, 2 mmol/L CaCl2, 1.2 mmol/L
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MgSO4, 25 mmol/L Hepes (pH 7.4), 0.2% BSA, and
2 lmol/L DCF-DA. Mitochondria were incubated in the
dark for 1 hour in the absence or presence of various test
substances, and then pelleted by centrifugation. DCF flu-
orescence was measured using a Spex spectrofluorimeter,
monitoring emission at 520 nm with an excitation wave-
length of 485 nm.
To assess dynamic changes in ROS production and to
assure that ROS generation was from mitochondria, iso-
lated mitochondria (0.5 mg mitochondrial protein) were
resuspended in a “respiring” buffer of 225 mmol/L man-
nitol, 75 mmol/L sucrose, 30 mmol/L Tris-HCl, pH 7.4, 5
mmol/L succinate, 0.1% BSA, and 5 lmol/L DCF-DA,
then treated with four additions of either 12.5 lmol/L
arachidonic acid or 5 lmol/L ceramide added at 100-
second intervals. Parallel experiments were performed
in the presence of 0.3 lmol/L rotenone, an inhibitor of
mitochondrial electron transport at complex I (Note: this
inhibitor also limits the backflux of electrons from com-
plex II to complex I that occurs when succinate is used as
a substrate) [36]. DCF fluorescence emission at 520 nm
(excitation = 488 nm) was monitored continuously be-
fore and after addition of lipid stimuli.
Lipid peroxidation
Lipid peroxidation in isolated mitochondria was as-
sessed using a commercially available kit (Calbiochem@)
(CN Biosciences, Inc., Darmstadt, Germany), which
monitors the production of malondialdehyde (MDA)
from a proprietary substrate that replaces thiobarbituric
acid in the reaction mixture [37]. Absorbance of the col-
ored reaction product formed in the isolated mitochon-
dria (2 to 5 mg mitochondrial protein per assay point)
was monitored spectrophotometrically at 586 nm.
Mitochondrial protein thiol redox status
The protein thiol redox status in isolated mitochon-
dria was assessed using a previously reported DTNB
[5,5-dithio-bis- (2-nitrobenzoic)] acid assay [38]. Isolated
mitochondria (1 to 5 mg protein) were incubated in the
absence or presence of test substance for 10 minutes. Sam-
ples were subjected to three successive freeze-thaw pro-
cedures to release matrix proteins, and then pelleted at
9000g for 5 minutes. Pellets were treated with 200 lL
of 6.5% trichloroacetic acid and protein precipitated by
centrifugation at 9000g for 5 minutes. This procedure
was repeated twice. The final pellet was suspended in
200 lL of DTNB solution [0.5% sodium dodecyl sulfate
(SDS), 0.5 mmol/L EDTA, 0.05 mol/L Tris-HCl, pH 8.3,
and 100 lmol/L DTNB] and 50 lg mitochondrial pro-
tein was added to 1 mL of DTNB solution. Thiol-protein
content was determined by measuring light absorption at
412 nm.
Statistical analysis
Data were analyzed with the SuperAnova software
package (Abacus Concepts Inc., Berkeley CA, USA),
using one-way analysis of variance (ANOVA) followed
by the Bonferroni/Dunn procedure for comparing indi-
vidual means to a single control group or by the Tukey-
Kramer honestly significant difference post hoc test for
making comparisons among multiple treatment means.
Experimental treatments were considered to have pro-
duced statistically significant effects when the probability
of chance occurrence was less than 0.05.
RESULTS
Oxalate, arachidonic acid, lyso-PC, and C2-ceramide
each decrease ∆Ψm in MDCK cells
Changes in m in MDCK cells were estimated by
monitoring changes in the fluorescence properties of JC-
1. Fluorescence scans from a typical MDCK monolayer
are shown in Figure 1A. MDCK cells were exposed se-
quentially to buffer (t = 0), to 0.5 mmol/L sodium oxalate
for 30 minutes and to FCCP for an additional 5 minutes,
and a fluorescence scan was taken at each of the three
time points. Relative to the initial control scan, oxalate
exposure produced an approximate 40% reduction in the
initial m, as estimated by the decreased JC-1 fluores-
cence at 596 nm and concomitant increased fluorescence
at 534 nm. Additional exposure to the mitochondrial un-
coupler FCCP (5 lmol/L) produced a further reduction in
the 596 nm/534 nm JC-1 fluorescence ratio in the oxalate-
treated cells to a ratio that was ∼39% of its initial value.
In additional experiments, the effects of oxalate,
arachidonic acid, lyso-PC, and C2-ceramide on MDCK
cell m were examined on additional coverslips of
MDCK cells. As summarized in Figure 1B, exposure to
sodium oxalate (0.5 mmol/L) produced a significant, over-
all ∼25% reduction in the 596 nm/534 nm JC-1 fluores-
cence ratio. Addition of FCCP produced a further de-
crease in m in the oxalate-treated cells to 46% of
the t = 0 value. In other experiments, treatment with
arachidonic acid (50 lmol/L), lyso-PC (25 lmol/L), or
C2-ceramide (20 lmol/L) for 30 minutes elicited 54%,
37%, and 51% declines, respectively, in MDCK cell
596 nm/534 nm JC-1 fluorescence ratios. In the C2-
ceramide–treated cells, addition of FCCP produced a fur-
ther decrease in the 596 nm/534 nm JC-1 fluorescence
ratio to about 36% of the starting value, although this was
not significantly different from the C2-ceramide value.
FCCP did not produce any further decrease in m in
the arachidonic acid–or lyso-PC–treated cells, suggesting
that exposure to these lipid signaling molecules maxi-
mally depolarized m in MDCK cells under the exper-
imental conditions.
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Fig. 1. Effect of oxalate and lipid-signaling
molecules on mitochondrial membrane po-
tential (∆Ψm) in Madin-Darby canine kidney
(MDCK) cells. MDCK monolayers were
loaded with 5,5′,6,6′-tetrachloro-1,1′,3,3′-
tetraethylbenzimidazolylcarbocyanine iodide
(JC-1) as described in the text and placed
in a spectrofluorimeter. Following excitation
at 488 nm, emission intensities (from 510 to
625 nm) were scanned three times: before
(control) (t = 0), then 30 minutes after
treatment with oxalate or lipids and finally
after addition of 5 lmol/L carbonyl cyanide
q-trifluoromethoxyphenylhydrazone (FCCP)
for 5 minutes. (A) Fluorimetric scans of JC-1
fluorescence for a representative coverslip of
MDCK cells. The spectrofluorimetric scan of
JC-1 fluorescence under control conditions (t
= 0) () revealed two emission peaks at 596
nm and at 534 nm. Exposure to 0.5 mmol/L
oxalate for 30 minutes () produced a shift in
the spectral properties of JC-1, increasing its
emission at 534 nm and decreasing its emis-
sion at 596 nm. Subsequent treatment with 5
lmol/L FCCP for 5 minutes (◦) produced a
further decrease at 596 nm and an increase
at 534 nm. The inset table summarizes the
596 nm/534 nm JC-1 fluorescence ratios
obtained from the three scans made for this
coverslip of MDCK cells [control, oxalate
(30 minutes), and oxalate (30 minutes) +
FCCP (5 minutes)]; data were normalized
to the initial t = 0 (control) 596 nm/534 nm
ratio. (B) Summary of effects of oxalate
and various lipids on JC-1 fluorescence.
JC-1 loaded MDCK monolayers were
treated for 30 minutes with oxalate (OX)
(0.5 mmol/L), arachidonic acid (AA) (50
lmol/L), lysophosphatidylcholine (lyso-PC)
(25 lmol/L), or C2-ceramide (C2-cer) (20
lmol/L), then treated with 5 lmol/L FCCP
for 5 minutes. The JC-1 emission spectrum
was scanned at time zero, then at 30 minutes
after addition of test substances and again
5 minutes after addition of FCCP. The JC-1
596 nm/534 nm fluorescence emission ratio
was calculated and used to estimate the loss
of m. In each experiment, data were
normalized to the initial (control) 596 nm/534
nm ratio. Data are expressed as mean ±
SEM for 6 to 24 individual experiments.
Each treatment led to a significant decrease
in mitochondrial membrane potential. ∗P <
0.01 relative to the t = 0 control; †P < 0.01 vs.
oxalate.
Inhibition of PLA2 with AACOCF3 attenuates the
oxalate-induced dissipation of ∆Ψm in intact MDCK
cells
Pretreatment of MDCK cells with 10 lmol/L AA-
COCF3, a selective inhibitor of cPLA2, attenuated the
decrease in m that would have otherwise occurred
after exposure to oxalate (Fig. 2A), supporting a role for
cPLA2 activation mediating the oxalate-induced changes
in m.
To confirm that AACOCF3 inhibits PLA2 activity in
MDCK cells, oxalate-induced arachidonic acid release
was measured in the presence or absence of the inhibitor.
Oxalate exposure elicited a 2.5-fold increase in [3H]-
arachidonic acid release from cells prelabeled with this
lipid (Fig. 2B), an effect that was partially blocked by
AACOCF3.
Oxalate, arachidonic acid, lyso-PC, and C2-ceramide
exposure promote activation of caspases in intact
MDCK cells
Previous studies had suggested that oxalate exposure
triggers both necrotic [10] and apoptotic cell death [7,
10] in renal epithelial cells. Caspases are serine proteases
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Fig. 2. Inhibition of phospholipase A2 (PLA2) attenuates oxalate-
induced decreases in mitochondrial membrane potential (∆Ψm) and
partially blocks oxalate-induced arachidonic acid release in Madin-
Darby canine kidney (MDCK) cells. (A) Coverslips of MDCK cells
were pretreated for 15 minutes with media alone or with media con-
taining 10 lmol/L arachidonyl trifluoromethyl ketone (AACOCF3)
[an inhibitor of cytosolic PLA2 (cPLA2)], loaded with 5 lmol/L
5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolylcarbocyanine io-
dide (JC-1) for 15 minutes, then exposed to 0.5 mmol/L sodium
oxalate (OX) for 30 minutes and finally to carbonyl cyanide q-
trifluoromethoxyphenylhydrazone (FCCP) for 5 minutes. JC-1 fluores-
cence in MDCK cells was scanned from 515 to 625 nm. Initial 596 nm/534
nm JC-1 fluorescence ratios were 5.3 ± 1.2, and 4.8 ± 1.1 for the control
and AACOCF3-treated coverslips, respectively. Data in the figure are
expressed as the mean ± SEM 596 nm/534 nm JC1-fluorescence ratio
normalized to the initial (t = 0) value, for four to seven independent
coverslips per group. Oxalate exposure significantly decreased m.
∗∗P < 0.01 vs. t = 0 in the absence (A, left panel) but not the presence (A,
right panel) of AACOCF3. FCCP reduced m to a similar extent in
both groups. §P < 0.01 vs. oxalate-treated. (B) MDCK cells were prela-
beled for 12 to 18 hours with 0.2 lCi [3H]-arachidonic acid, washed,
pretreated for 10 minutes with AACOCF3 or with Dulbecco’s modi-
fied Eagle’s medium (DMEM) alone, then challenged with 1 mmol/L
oxalate for 60 minutes. Data are expressed as mean ± SEM release of
[3H]-arachidonic acid relative to control. There were 12 observations
per group from four independent experiments. Oxalate exposure pro-
moted significant release of [3H]-arachidonic acid, an effect that was
partially blocked AACOCF3 treatment. ∗∗P < 0.01 vs. control; ††P <
0.01 vs. oxalate-treated.
that play a central role in the execution phase of apop-
tosis, triggering many of the morphologic changes asso-
ciated with this form of cell death [24, 25]. To determine
whether exposure to oxalate or the lipids generated in
response to oxalate exposure would activate caspases in
MDCK cells, caspase activity was monitored microscopi-
cally, estimating the number of caspase-positive cells with
a fluorescent substrate that binds to known isoforms of
active caspases. Exposure to oxalate, arachidonic acid,
lyso-PC, or C2-ceramide each led to significant increases
in the number of MDCK cells that stained positively for
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Fig. 3. Caspase activation in Madin-Darby canine kidney (MDCK)
cells in response to oxalate and to lipid-signaling molecules. MDCK
monolayers were exposed for 1 hour to oxalate (0.5 mmol/L), arachi-
donic acid (50 lmol/L), lysophosphatidylcholine (lyso-PC) (25 lmol/L),
C-2 ceramide (20 lmol/L), or antimycin A (0.2 lmol/L), a mitochondrial
inhibitor. Cells were then labeled with the CaspaTagTM kit and exam-
ined under a fluorescent microscope to identify cells that expressed
activated caspases. Caspase-positive cells were counted in 15 randomly
selected microscopic fields and the average number of caspase-positive
cells/field was determined for each treatment. Data are expressed as
mean ± SEM caspase-positive cells from three independent experi-
ments. Each treatment elicited a significant increase in caspase-positive
MDCK cells. ∗∗P < 0.01 vs. control.
caspases, as summarized in Figure 3. Antimycin A, a mi-
tochondrial electron transport inhibitor that is known to
activate caspases in other cell lines including renal cells
[31] also increased caspase activation in MDCK cells.
Oxalate, arachidonic acid, lyso-PC, and C2-ceramide
induce mitochondrial ROS generation, promote
lipid peroxidation, and deduce thiol protein
Studies were carried out on isolated renal mitochon-
dria to determine whether oxalate or lipid-signaling
molecules known to be increased by oxalate exposure
elicited direct mitochondrial effects on mitochondrial
oxidant status. Acute changes in free radical produc-
tion were assessed in isolated respiring rat kidney mi-
tochondria by monitoring conversion of nonfluorescent
DCF-DA to fluorescent DCF. Results from a typical ex-
periment that tested the effects of arachidonic acid on
mitochondrial ROS production are shown in Figure 4A.
Increased DCF fluorescence was noted in the upper trace
following the addition of 5 mmol/L succinate, a respira-
tory substrate, and again with each of four successive ad-
ditions of 12.5 lmol/L arachidonic acid. Similar changes
in ROS production were also observed in response to C2-
ceramide (data not shown). Increased DCF fluorescence
can be ascribed in part to increased ROS production dur-
ing mitochondrial respiration, since this increase was par-
tially impeded by rotenone (0.3 lmol/L, lower trace), an
inhibitor of mitochondrial respiratory chain complex I.
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Fig. 4. Studies in isolated kidney cortex mitochondria. (A) Acute generation of reactive oxygen species (ROS). Isolated renal cortex mitochondria
were loaded with 2′, 7′-dichloro-dihydrofluorescein-diacetate (DCF-DA), and production of ROS was estimated over a 10-minute interval by
monitoring conversion of non-fluorescent DCF-DA to DCF, its fluorescent metabolite, by monitoring emission at 520 nm with an excitation
wavelength of 485 nm using a Spex spectrofluorimeter. This representative experiment was conducted in the absence (upper trace) or presence
(lower trace) of 0.3 mmol/L rotenone, an inhibitor of mitochondrial electron transport at complex I, added just prior to experiment. DCF fluorescence
was continuously monitored under basal conditions for 100 seconds, then for100 seconds following the addition of 5 mmol/L succinate (to induce
respiration) and finally in response to four separate additions of 12.5 lmol/L arachidonic acid made at 100 second intervals; arrows indicate additions
of succinate or arachidonic acid. The addition of succinate and each addition of arachidonic acid produced an increase in DCF fluorescence in the
control mitochondria, consistent with ROS generation. These increases were blunted by prior addition of rotenone. (B) ROS formation in response
to oxalate and signaling lipid molecules. ROS formation in isolated kidney mitochondria was monitored by changes in DCF fluorescence measured
at 60 minutes after addition of oxalate (OX) (0.5 mmol/L), arachidonic acid (AA) (50 lmol/L), lysophosphatidylcholine (lyso-PC) (25 lmol/L),
or C-2 ceramide (C2-cer) (20 lmol/L). Each bar depicts mean DCF fluorescence intensity ± SEM (normalized to control) for six independent
observations per treatment group. ∗∗P < 0.01 vs. control. (C) Formation of lipid peroxides. Mitochondrial content of lipid peroxides was measured
using a malondialdehyde (MDA) assay, following the addition of oxalate or various lipid signaling molecules to isolated kidney cortex mitochondria
for 1 hour (OX) (0.5 mmol/L), arachidonic acid (AA) (50 lmol/L), lysophosphatidylcholine (lyso-PC) (25 lmol/L), or C-2 ceramide (C2-cer)
(20 lmol/L). Each bar depicts mean MDA formed (nmol/mg mitochondrial protein) ± SEM for six to eight observations per treatment group.
Each treatment increased lipid peroxidation by isolated renal cortex mitochondria. ∗P < 0.05; ∗∗P < 0.01 vs. control. (D) Reduced thiol protein.
Reduced protein thiol content (SH-protein) was estimated in isolated mitochondria using a 5,5-dithio-bis- (2-nitrobenzoic) DTNB assay. Isolated
mitochondria were exposed to oxalate or lipids for 1 hour (OX) (0.5 mmol/L), arachidonic acid (AA) (50 lmol/L) lysophosphatidylcholine (lyso-PC)
(25 lmol/L), or C-2 ceramide (C2-cer) (20 lmol/L). Each bar depicts the mean reduced thiol protein (lg/mg mitochondrial protein) ± SEM for 9
to 10 observations per treatment group. Each treatment produced a significant loss of reduced thiol-protein. ∗∗P < 0.01 vs. control.
In other studies, the effects of a 60-minute mito-
chondrial exposure to oxalate (0.5 mmol/L), arachidonic
acid (50 lmol/L), lyso-PC (25 lmol/L), or C2-ceramide
(20 lmol/L) on ROS production were examined. As sum-
marized in Figure 4B, each treatment led to a significant
increase in free radical production in isolated kidney mi-
tochondria as evidenced by increased DCF fluorescence.
Other studies analyzed the effects of oxalate and
lipids on mitochondrial lipid peroxidation and on re-
duced thiol protein levels. Exposure for 60 minutes to
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oxalate (0.5 mmol/L), arachidonic acid (50 lmol/L), lyso-
PC (25 lmol/L), or C2-ceramide (20 lmol/L) each led to
significant increases in lipid peroxidation in isolated mi-
tochondria (Fig. 4C) and to significant declines in reduced
thiol protein, as shown in Figure 4D.
The extent to which oxidation of exogenously added
lipids might have contributed to the observed increase
in lipid peroxides or to the observed increase in DCF
fluorescence is not known. Arachidonic acid has the po-
tential of being oxidized in the presence of actively respir-
ing mitochondria and hence, could potentially contribute
to the lipid peroxides measured in these studies. How-
ever, isolated mitochondria were provided with an excess
(5 mmol/L) of other substrate in these assays as well as
BSA (0.2%), which should minimize such nonspecific ef-
fects. Moreover, comparable increases in lipid peroxides
were found following exposure to oxalate, arachidonic
acid, lyso-PC, and C2-ceramide, a finding that seems un-
likely if certain lipid byproducts products were contribut-
ing appreciably to the observed changes.
DISCUSSION
Exposure to oxalate in crystal or ionic form has been
shown by many investigators to induce cell death in cul-
tured renal epithelial cells [1–12]. The manner by which
renal cells are killed following oxalate exposure has not
been entirely resolved, although there is evidence for
both necrotic [10] and apoptotic death [7, 10, 39]. The
current studies add support to a role for oxalate-induced
apoptotic death in MDCK cells, since exposure to ox-
alate, or to a variety of lipid signaling molecules that are
generated in response to oxalate, promoted an increased
staining for caspases, serine proteases whose activity of-
ten increases in apoptosis [24, 25]. Apoptosis and necrosis
are often preceded by mitochondrial dysfunction, in par-
ticular, a loss of m [21–23]. Hence, the present studies
explored the link between oxalate exposure and m in
cultured renal epithelial cells.
The present studies used JC-1 to estimate qualitative
changes in m. Although JC-1 has been used for at least
a decade to probe various factors that influence m
[26], it has been noted that the equilibrium between JC-1
monomers, dimers, and polymers may not be solely in-
fluenced by changes in m, since JC-1 is pH-sensitive
and its absorption spectrum may be affected by the os-
molarity of its environment or by the presence of a dis-
sociated acid. Recent studies [40] suggest that at least in
a mixed aqueous/ethanol solution, it is the JC-1 aggre-
gates that are most sensitive to dissociated acid, whereas
monomers are less vulnerable to decreases in pH. In the
present experiments in intact MDCK cells, (monomeric)
JC-1 fluorescence routinely increased at 534 nm in re-
sponse to adding 0.5 mmol/L oxalate at the same time
that (aggregated) JC-1 fluorescence at 596 nm was
decreasing. Although a nonspecific decrease in the flu-
orescence of the aggregated dye could artefactually de-
crease the 596 nm/534 nm fluorescence ratio, the in-
creased JC-1 fluorescence at 534 nm was an important
contributor to the changes in JC-1 fluorescence ratios
reported in the present work, whether induced by ox-
alate, lipids, or FCCP. Moreover, in studies in which the
response to oxalate was examined in the presence and
absence of 10 lmol/L AACOCF3, the addition of this
PLA2 inhibitor attenuated the oxalate-induced decrease
in the 596 nm/534 nm JC-1 fluorescence ratio even though
comparable amounts of dissociated oxalic acid were still
present in each instance, suggesting that oxalate proba-
bly did not produce a nonspecific effect on the pattern of
JC-1 fluorescence.
Exposure to oxalate led to rapid, reproducible de-
creases in m in intact MDCK cells, as assessed by
shifts in JC-1 fluorescence ratios, suggesting that mito-
chondria are indeed targets for oxalate-induced toxicity.
Given the relatively brief exposure to oxalate in these
studies, it is likely that the observed mitochondrial re-
sponses are induced by oxalate in solution, rather than
by oxalate crystals. Although the calcium, oxalate, and
hydrogen ion concentrations in the culture media could
potentially favor formation of calcium oxalate crystals,
the process would require ∼3 hours to reach equilib-
rium [41]. We did not observe any overt calcium oxalate
crystal formation during the measurement period used in
these short-term studies (∼30 minutes) but microcrystals
may well have formed, and could potentially have influ-
enced cellular processes. Assessment of the influences of
calcium oxalate crystals on renal mitochondrial function
awaits study.
Two lines of evidence suggest that activation of PLA2
plays a role in these mitochondrial responses to oxalate.
First, the oxalate-induced decline in m was attenu-
ated by AACOCF3. This cPLA2 inhibitor partially atten-
uates the oxalate-induced increases in arachidonic acid
and lyso-PC [13] (Fig. 2). Further, AACOCF3 blocks the
oxalate-induced formation of ceramide in renal epithelial
cells [14], most likely by blocking neutral sphingomyeli-
nase activation, through a process that reflects cross-talk
between the PLA2 and the sphingomyelinase signaling
pathways, rather than a direct effect of the inhibitor on
the enzyme. Indeed, Jayadev et al [42] suggest that cPLA2
activation is a necessary component of the pathways lead-
ing to ceramide accumulation and cell death.
The second line of evidence implicating a role for PLA2
in control of m is the observation that direct ex-
posure to arachidonic acid, lyso-PC or C2-ceramide—
lipid signaling molecules generated in response to ox-
alate exposure—also decreased m in MDCK cells.
The mechanisms by which oxalate-induced lipid signals
trigger a decrease in m in kidney cells have not yet
been elucidated, although promotion of a mitochondrial
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membrane permeability transition (MPT) is one possibil-
ity [39, 40]. MPT is a process by which mitochondria be-
come freely permeable to solutes less than about 1500 D;
and in many cells, this process depolarizes m and leads
to apoptotic or necrotic cell death [21, 22]. Lipid signal-
ing molecules have been implicated as mediators of MPT
in several different tissues. For example, arachidonic acid
promotes mitochondrial MPT in isolated liver mitochon-
dria [45] and ceramide stimulates MPT in mouse fibrob-
lasts [46]. Further work will be needed to determine the
role played by MPT in the oxalate-induced depolariza-
tion of m in MDCK cells.
Oxidant stress plays a key role in oxalate-induced re-
nal cell toxicity. Many studies have demonstrated that
concomitant exposure to exogenous antioxidants will at-
tenuate many of the effects of oxalate on cell viability and
gene expression [3, 4, 6, 11, 12, 18, 19]. Mitochondria, as
sites of aerobic metabolism, are likely to be a significant
source of intracellular ROS [20], and cellular injury or
stress often increases ROS accrual by mitochondria [47,
48]. Indeed, mitochondria appear to be a major source
of the superoxide that is produced in MDCK cells fol-
lowing exposure to oxalate in its soluble or crystalline
form, since inhibitors of the mitochondrial proton gra-
dient also inhibited oxalate-induced superoxide genera-
tion [17]. Thus, the present finding that oxalate exposure
decreased m in renal epithelial cells is of particular
interest because the loss of m can be a precursor to
ROS production in many cells [47].
The present studies indicate that the lipid signaling
molecules generated in response to oxalate exposure
can directly increase mitochondrial oxidant stress. Expo-
sure of isolated renal mitochondria to arachidonic acid,
lyso-PC, or C2-ceramide enhanced the mitochondrial
generation of ROS and lipid peroxides, and decreased
available endogenous antioxidants by lowering the
amount of available reduced thiol protein. Although the
mechanisms by which these lipids interact with renal
mitochondria to increase ROS have not yet been clari-
fied, studies performed in isolated respiring bovine heart
mitochondria indicated that arachidonic acid uncouples
electron transport and increases hydrogen peroxide pro-
duction via complexes I and III in the mitochondrial res-
piratory chain [35]. Similarly, arachidonic acid increased
hydrogen peroxide formation in isolated rat diaphragm
mitochondria by interacting with complex I of the elec-
tron transport chain [49]. Ceramide too has been shown
to increase mitochondrial production of peroxides in
rat heart mitochondria [50] and also in human myeloid
leukemia cells [51] through direct interaction with com-
plex III in the mitochondrial respiratory chain. In the
present studies, which used succinate as a substrate, addi-
tion of arachidonic acid or C2-ceramide increased ROS
production in isolated renal mitochondria. Under such
conditions, electrons can backflux from complex II via
succinate dehydrogenase to complex I. The addition of
rotenone reportedly inhibits this backflux [36] and thus,
decreases ROS production. Note also that in studies on
diaphragm muscle mitochondria (supplied with malate +
pyruvate), Nethery et al [49] observed that arachidonic
acid elicited an increase in H2O2 production that could
be inhibited by rotenone. Further work will be needed
to identify specific target sites within the renal mitochon-
drial respiratory chain at which arachidonic acid, lyso-PC,
and ceramide act to promote ROS production.
Although oxalate, arachidonic acid, lyso-PC, and ce-
ramide had similar effects on mitochondria with regard
to the production of ROS and lipid peroxides (Fig. 4),
these agents generated differential effects on caspase ac-
tivation (Fig. 3), with oxalate being the poorest activator
of caspases under the current experimental conditions.
This apparent disparity may be due to a variety of fac-
tors. For one, prior studies on oxalate toxicity indicated
that oxalate only kills a modest fraction of the renal cells
(15% to 30%) even at concentrations above 1 mmol/L [3,
4]—a finding that could reflect a process by which cellular
antioxidants must be exhausted before toxic effects are
manifested. Exogenous lipid signals on the other hand
presumably affected all of the cells in these experiments.
Another possibility is that oxalate actions may be some-
what circumscribed under the present culture conditions
in which oxalate was added to the apical surface of conflu-
ent monolayers; recent studies by Evan et al [52] suggest
that the basolateral surface of renal cells may be more
sensitive to oxalate.
The relationship between the increased production of
ROS and the release of mitochondrial factors that ac-
tivate caspases is also not fully understood, nor is it
clear that increased caspase activation necessarily leads
to parallel increases in the numbers of dead cells. Mito-
chondria have been shown to release apoptogenic fac-
tors that propagate cell death via caspase-independent
as well via caspase-dependent processes [53]. It is pos-
sible that the various agents tested in the present stud-
ies produced differential effects on the types of factors
released by mitochondria, and moreover, possible that
some of these agents may exert more than one effect
on the mitochondria. For example, prior studies in heart
mitochondria showed that arachidonic acid could inter-
act with the electron transport system to increase ROS
production [34, 49]. Other studies demonstrated a di-
rect inhibition of mitochondrial electron transport by
short-chain ceramides [50]. The latter molecules may
also exert additional effects on the integrity of mito-
chondrial membranes, which might explain the marked
increase in caspase staining after ceramide treatment.
One of the recognized problems with short chain ce-
ramides (used because they are water soluble whereas
native ceramide is not) is that these molecules create
disorder (increased fluidity) in the membrane and cause
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lipid-packing defects within the bilayer [54]. Such differ-
ential effects of various lipids on the mitochondrial mem-
brane could potentially explain some of the differences
between the various mitochondrial actions of lipid signal-
ing molecules.
The present studies suggest that in addition to promot-
ing the formation of lipid signaling molecules, oxalate
per se may also influence mitochondrial ROS gener-
ation through its own direct interactions with kidney
mitochondria. Although the processes that potentially
mediate these direct mitochondrial responses to oxalate
are still unknown, mechanisms for cellular and mito-
chondrial uptake of oxalate have been described [55–
58]. Indeed, early studies demonstrated that high con-
centrations of oxalate produce apparent changes in the
permeability of the inner mitochondrial membrane [57].
Whether these mitochondrial effects of oxalate are di-
rect or secondary to the production of lipid signals within
these organelles is as yet unknown, although studies in
other systems have identified mitochondrial phospholi-
pases that appear to be involved in apoptotic responses
[59, 60]. In the present work, oxalate appears to have ac-
tivated more than one PLA2 isoform, since only a portion
of the oxalate-induced liberation of arachidonic acid was
blocked by a cPLA2 inhibitor (Fig. 2). The identity of
this (these) additional PLA2 isoform(s) has not yet been
explored. It is also possible that mitochondrial pools of
ceramide may also play a role in cell death, as has been
observed in MCF-7 breast cancer cells [61]. Further work
will be needed to determine whether intracellular oxalate
concentrations rise to the level need to produce the direct
oxalate effects observed in the present studies isolated
mitochondria, and if so, to identify the mitochondrial ef-
fectors of these responses.
How does the oxalate-induced oxidant stress that is
observed in cultured renal epithelial cells relate to the
renal sequelae of hyperoxaluria in vivo? There is evi-
dence suggesting that in experimental hyperoxaluria in
vivo, renal levels of reactive oxygen molecules and lipid
peroxides are increased, while endogenous antioxidants
are depleted [62]. Further work will be needed to de-
termine whether increased mitochondrial ROS produc-
tion is a feature of human kidney stone disease and if
so, whether manipulation of renal mitochondrial redox
status could potentially play a role in the prevention or
treatment of stone disease.
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